• Home
  • A-B index
  • Pharmacological Index
  • Drug Classes
  • Active Ingredients
  • Companies
  • News
  • Taro International Ltd

    Drugs Disributed by Taro International Ltd

    Bortezomib Taro 3.5 mg
    Taro International Ltd
    not in the basket chart
    Bortezomib Taro 3.5 mg

    Proteasome Inhibitor. Bortezomib 3.5 mg.
    VIAL (Pwdr. for sol. for inj.): 1×3.5 mg. Dosage should be ajust. individ. See lit.
    Multiple Myeloma.
    Mantle Cell Lymphoma: For the tmt. of pts/ with mantle cell lymphoma who have received at least one prior ther.
    Bortezomib in comb. with rituximab, cyclophosphamide, doxorubicin & prednisone is indicated for the tmt. of adult pts. with previous. untreat. mantle cell lymphoma who are unsuitable for haematopoietic stem cell transplantation.
    C/I: Hypers. to bortezomib, boron or mannitol. Acute diffuse infiltrative pulmon. and pericard. dis. Intrathecal admin.